Ovid Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD | 02/12/2025 | 7.53 M | $7.01 M | 0.00% | 10.61% |
| RUBRIC CAPITAL MANAGEMENT LP | 02/14/2025 | 5.32 M | $4.96 M | 0.00% | 7.49% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.93 M | $3.67 M | -8.94% | 5.54% |
| BVF INC/IL | 02/14/2025 | 3.85 M | $3.60 M | 0.00% | 5.43% |
| MADISON AVENUE PARTNERS, LP | 02/14/2025 | 3.72 M | $3.48 M | -9.57% | 5.24% |
| VANGUARD GROUP INC | 02/11/2025 | 3.15 M | $2.94 M | 0.18% | 4.44% |
| SIREN, L.L.C. | 02/14/2025 | 2.85 M | $2.66 M | 0.00% | 4.02% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 1.85 M | $1.73 M | 0.18% | 2.61% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 1.55 M | $1.44 M | 1.14% | 2.18% |
| JPMORGAN CHASE & CO | 02/12/2025 | 1.42 M | $1.32 M | -3.11% | 2.00% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.40 M | $1.31 M | 0.00% | 1.97% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.33 M | $1.24 M | 0.92% | 1.87% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.00 M | $933,700 | 100.00% | 1.41% |
| SIO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.00 M | $933,700 | 100.00% | 1.41% |
| UBS OCONNOR LLC | 02/14/2025 | 943,416 | $881,151 | 50.16% | 1.33% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 743,807 | $694,492 | 1.17% | 1.05% |
| TLS ADVISORS LLC | 02/13/2025 | 680,967 | $636,000 | -11.74% | 0.96% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 229,115 | $213,925 | -25.98% | 0.32% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 198,123 | $184,988 | 52.08% | 0.28% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 165,763 | $154,774 | 0.00% | 0.23% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 161,808 | $151,080 | 0.00% | 0.23% |
| VERITION FUND MANAGEMENT LLC | 02/14/2025 | 147,305 | $137,539 | 96.73% | 0.21% |
| EMPOWERED FUNDS, LLC | 01/28/2025 | 138,415 | $129,238 | -4.76% | 0.20% |
| 02/10/2025 | 138,266 | $129,099 | 100.00% | 0.19% | |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 130,532 | $121,878 | 245.84% | 0.18% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 123,583 | $115,000 | -52.56% | 0.17% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 119,113 | $111,216 | 0.00% | 0.17% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 107,700 | $100,559 | 142.02% | 0.15% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 105,177 | $97,815 | 0.00% | 0.15% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 104,712 | $97,770 | -52.49% | 0.15% |
| BARCLAYS PLC | 02/13/2025 | 93,307 | $87,000 | 10.85% | 0.13% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 92,971 | $86,886 | -10.61% | 0.13% |
| RHUMBLINE ADVISERS | 01/30/2025 | 84,078 | $78,521 | 22.34% | 0.12% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 70,114 | $65,465 | -18.75% | 0.10% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2025 | 70,000 | $65,359 | 100.00% | 0.10% |
| UBS GROUP AG | 02/14/2025 | 60,767 | $56,757 | 98.51% | 0.09% |
| CITIGROUP INC | 02/12/2025 | 48,551 | $45,332 | 10.46% | 0.07% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 47,780 | $44,612 | -0.21% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 45,120 | $42,129 | 100.00% | 0.06% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 35,530 | $33,174 | 4.24% | 0.05% |
| FMR LLC | 02/13/2025 | 34,916 | $32,601 | -30.48% | 0.05% |
| COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 29,279 | $27,338 | -7.02% | 0.04% |
| INVESCO LTD. | 02/13/2025 | 27,207 | $25,403 | -7.26% | 0.04% |
| FIRST MANHATTAN CO. LLC. | 02/14/2025 | 26,000 | $24,276 | 0.00% | 0.04% |
| INTECH INVESTMENT MANAGEMENT LLC | 02/11/2025 | 23,724 | $22,151 | 100.00% | 0.03% |
| BLAIR WILLIAM & CO/IL | 02/12/2025 | 23,039 | $21,512 | -28.09% | 0.03% |
| NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 18,986 | $18,000 | 0.00% | 0.03% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 17,396 | $17,000 | 0.00% | 0.02% |
| PROSHARE ADVISORS LLC | 02/14/2025 | 16,584 | $15,485 | 8.24% | 0.02% |
| NEWMAN DIGNAN & SHEERAR, INC. | 01/30/2025 | 16,522 | $15,427 | 0.00% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ovid Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 94 institutional investors and hedge funds held shares of Ovid Therapeutics Inc.. The most heavily invested institutionals were:
TAKEDA PHARMACEUTICAL CO LTD: 7.53 M
Rubric Capital Management LP: 5.32 M
BlackRock Funding, Inc. /DE: 3.93 M
BVF INC/IL: 3.85 M
Madison Avenue Partners, LP: 3.72 M
VANGUARD GROUP INC: 3.15 M
67.02% of Ovid Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 51.72 M shares in the last 24 months. This purchase volume represents approximately $49.13 M in transactions.